Prohibited Medicines List
A
drug banned / restricted in one country may continue to be marketed in other
countries as the respective governments examine the usage, doses, indications
permitted etc. and overall risk benefits ratio and take decisions on the
continued marketing of any drug in these countries.
Safety
issues of drug formulations, as and when reported, are assessed in consultation
with the Expert Committees / Drugs Technical Advisory Board (DTAB). Based on
the recommendations of the Expert Committees / DTAB, the Central Government
prohibits manufacture, sale and distribution of such drugs in the country
through Gazette Notification.
The Central Government has prohibited /
suspended manufacture, sale and distribution of following drugs during the last
three years and in the current year in the country through Notifications in the
Gazette of India:
1.
Rosiglitazone.
2.
Nimesulide
formulations in children below 12 years of age.
3.
Cisapride
and its formulations for human use.
4.
Phenylpropanolamine and its formulations forhuman use.
5.
Human Placental Extract and its
formulations for human use except its
(i) Topical application for wound healing, and
(ii) Injection for pelvic inflammatory disease.
6.
Sibutramine
and its formulations for human use.
7.
R-Sibutramine and
its formulations for human use.
8.
Gatifloxacin
formulation for systemic use in human by any route including oral and
injectable
9.
Tegaserod
and its formulations
10. Letrozole
for induction of ovulation in anovulatory
infertility.
11. Serodiagnostic
test kits for diagnosis of tuberculosis
12. Dextropropoxyphene
and formulations containing Dextropropoxyphene for
human use.
13. Fixed
dose combination of Flupenthixol + Melitracen for human use
14. Analgin
and all formulations containing analgin for human
use.
This information was given by Union Minister
of Health & Family Welfare Ghulam Nabi Azad, in written reply to a question in the Rajya Sabha on 13 August 2013.
[Source: PIB (Ministry of Health and Family
Welfare) Press Release dated 13th August 2013]